Sudden, unexpected, unexplained death can be defmed as death within one hour of symptoms (excluding suicide, homicide, and accident) (Ungvari, 1980) which was both unexpected in relation to the degree of disability before death (Kuller eta!, 1967) and unexplained because clinical investigation and autopsy failed to identify any plausible cause (Hirsch & Martin, 1971) . It is common in the elderly, but the percentage of deaths meeting these criteria is actually higher in younger persons (Kannel & Thomas, 1982) . The usual mechanism of death is believed to be ventricular fibrillation; this suggests that patients with cardiac arrhythmias are at risk (Lown, 1987) . However, many other causes and mechanisms exist. Indeed, factors may coexist; for example, psychological factors may trigger neurological circuits, release catecholamines peripherally, or both, and thereby modify cardiac physiology (Lown, 1987) .
The death rate among psychiatric patients tends to be higher than that of the general population, suicide being an important factor. However, the literature contains many case reports of psychiatric patients treated with antipsychotic medication who died suddenly, unexpectedly, and without apparent cause. The possible association between such deaths and the antipsychotic medication itself has been reviewed, most authoritatively by a task force of the American Psychiatric Association who concluded: â€oe¿ The role played by the drug in a given individual is difficult, if not impossible, to determineâ€• (Task Force Report, 1988; p. 25) . Nevertheless, the pharmacologic and toxicologic properties of the antipsychotic drugs in general is such that cardiotoxicity, especially at higher doses, cannot be excluded, and for some drugs, such as thioridazine (Mehtonen et a!, 1991) and pimozide (Fulop et a!, 1987) , major cardiac effects are well documented.
What is unclear, however, is whether sudden deaths are more likely to occur in patients treated with antipsychotic drugs. The relationship of sudden death to dosage of antipsychotic drugs and to disturbed behaviour is also baffling. Some patients are on high doses, some are not, and still others are on equally high doses with apparent impunity. However, in overdose, striking cardiac abnormalities in function and rhythm occur (Moss & Schwartz, 1980) . Post-mortem blood sampling and estimation of drug concentrations is now feasible, and these procedures might be expected to help, firstly in establishing the cause of death, and secondly, in suggesting ways of minimising the risk. The purpose of this paper is to present some data from eight consecutive cases in the medico-legal experience of Malcolm Lader for which post-mortem plasma drug concentration data were available. The implications of these data for the management of patients requiring antipsychotic medication will then be discussed.
In presenting the case histories, it is appropriate to draw attention (in bold type) to probable toxic drug concentrations in blood (but not tissues). However, far fewer data are available than with the antidepressants. Indeed, even therapeutic ranges became very aggressive and was treated with oral daily doses of chlorpromazine (1000â€"1400 mg), haloperidol (10 mg), thioridazine (400 mg), and procycidine (40mg daily) together with haloperidol decanoate (400mg i.m. every 2 weeks). She was found dead in bed. At autopsy, a few isolated petechial haemorrhages in the lungs were noted. Concentrations in the plasma were chlorpromazine (7000 @sg/l) and thioridazine (4000 @sg/1), and the liver contained chlorpromazine (270 sg/g) and thioridazine (48 @ag/g).
Case2
. A man aged31, of Afro-Caribbean origin, was treated several times for schizophrenia. He became disturbed and increasingly violent, and after droperidol (up to 160 mg/day) had proved ineffective, he was treated with haloperidol (up to 120mg/day). The patient remained ill and continued to have symptoms. He was restrained and injected with promazine (150 mg), and then fluphenazine decanoate (150 mg) in the buttocks. He died within a few minutes of the second injection. At autopsy, the lungs showed haemorrhagic oedema and partial collapse, and the heart had small areas of myocardial fibrosis. The post-mortem blood sample contained promazine (82 @ig/1) and fluphenazine (4 @sg/l) in heart blood, but these drugs were not detected in the leg blood samples. Haloperidol was detected in neither sample.
Case3
. A white man aged 29 with the diagnosis of paranoid schizophrenia was admitted to hospital. Because of his violent behaviour, he was given several different antipsychotic medications, namely fluphenazine decanoate (250mg i.m. weekly), chiorpromazine(200mg four times daily), trifluoperazine (10mg four times daily), and haloperidol (10mg orally). Despite this therapy, he continued to be violent and to struggle, and he was injected i.m. with diazepam (10 mg) and haloperidol Table 1 Normal and toxic concentrations of some antipsychotic and otherdrugs (20 mg). He suddenly became cyanosed and died. At autopsy, the lungs were severely congested. Blood concentrations from a post-mortem specimen were chlorpromazine (1000 @sg/l),and trifluoperazine (800 @sg/l), haloperidol being found in only a very low concentration.
Case 4. A white man, aged 21, was treated for very disturbed and violent behaviour, with trifluoperazine (15 mg/day) and pimozide (20mg every morning). The dosage of pimozide was increased to 40mg. The patient suddenly collapsed and died. At autopsy, lung petechiae with a moderate degree of pulmonary oedema were noted. The post-mortem blood concentration of trifluoperazine was 50 @sg/l. However, pimozide was not detected in the plasma, and concentrations in the liver were lower than 5 @sg/100 mg. No other drugs, except for trace amounts of drug metabolites, were detected.
Case 5. A 68-year-old white woman was admitted to hospital because of psychotic symptoms. She had received several different drugs being treated with thyroid hormone for chronic thyroiditis. On admission, she was prescribed clomipramine (300 mg/day), chiorpromazine (up to 3000 mg/day), haloperidol(5 mg four times a day), and procyclidine (15 mg/day). She had a grand mal fit and soon afterwards died. At autopsy, the lungs were water logged. Post-mortem plasma drug concentrations were as follows: clomipramine (3000 @sg/l), chlorpromazine (500 @ig/l), haloperidol (200 @tg/1), and procycidine (2800 @ag/l).
Case 6. A white woman, aged 34 years, was admitted to hospital because she was agitated and disinhibited. Because of failure to improve, her medication was steadily increased until she received each day lithium (800 mg), chlorpromazine (400 mg), lorazepam (2.5 mg), and temazepam (10 mg). She died suddenly, without warning. At autopsy, no cause of death was found (apart from laceration of the liver attributed to resuscitation attempts). Blood drug concentrations were lithium (0.55 mmol/l), lorazepam (50 @g/l), temazepam (150 @tg/l), chlorpromazine (970 @tg/l), and procyclidine (650 @&g/l).
Case 7. A 27-year-old Afro-Caribbean man suffering from schizophrenia was treated with fluphenazine, haloperidol, pimozide, and procydidine. He had had palpitations in the past, but he refused an electrocardiogram. Because of his violent behaviour, he was seen at home, forcibly restrained, and injected intravenously with haloperidol (20mg) and diazepam (20 mg). The patient had a cardiac arrest soon afterwards and died. No evidence of disease or injury which would account for his death was found at autopsy. A blood sample taken immediately after death contained concentrations of diazepam (430pg/l) and haloperidol (30tg/l). A later bloodsampleatautopsy showed diazepam and haloperidol at concentrations of approximately 250 pg/l and 200 @tg/l, respectively. A post-mortem liver sample contained haloperidol at a concentration of 0.3 @ig/gof tissue.
Case 8. A 36-year-old man suffered a severe depressive psychosis. He was admitted to hospital because he was very agitated, and he was prescribed chlorpromazine (350 mg four times a day), fluvoxamine (100mg twice daily), droperidol (20mg daily), and procycidine (5 mg daily). A few days later he was given, at the same time, chlorpromazine (700mg orally), fluvoxamine (100mg orally), chlorpromazine (100mg i.m.), and droperidol (20mg i.m.). He was found cyanosed in bed and died despite attempts to revive him. At autopsy, no significant abnormality was found. Post-mortem blood drug concentrations were chlorpromazine (4700 pg/l) and fluvoxamine (895 @tg/l).
Discussion
Before we attempt to collate these eight case reports, it is necessary to assess the validity of antipsychotic drug concentrations in blood taken post-mortem, usually from the heart at autopsy. So complicated are the factors governing post-mortem drug concentrations that this topic has been dubbed a â€oe¿ toxicological nightmareâ€• (Pounder & Jones, 1990) . Antidepressants, so often used in overdose, have been the subject of some studies (Prouty & Anderson, 1990) ; the physicochemical properties and pharmacokinetic profiles of many antipsychotic drugs are sufficiently similar to allow some broad conclusions to be drawn.
For some drugs, depending mostly on lipophilicity (fat solubility), marked differences are found post mortem in blood concentrations taken from different sites (Jones & Pounder, 1987) . These differences are believed to reflect post-mortem diffusion of drugs from reservoirs such as the lungs and liver into nearby blood vessels. Consequently, cardiac blood tends to have much higher concentrations than peripheral blood, from, say, a leg or forearm vein. Furthermore, movement of blood in the great vessels may occur during the development of rigor mortis and later incipient putrefaction. The extent of post mortem diffusion depends on the ante-mortem distribution patterns of each individual drug. Those with high volumes of distribution, indicating concentration in tissues such as the liver, are more affected than those with low volumes of distribution.
The practical implication is that one must be cautious in interpretation of drug concentrations in post-mortem blood sampled from the great vessels or heart. These values may be too high by a significant amount. Secondly, peripheral blood values are much more reliable and can provide useful guidance. Thirdly, post-mortem liver concentrations may be underestimates. These reservations apply not only to cases of sudden death but also to apparent suicidal overdoses in which therapeutic drug concentrations may be magnified by the factors outlined above.
With these caveats, some tentative observations can be made. Patient 2 had antipsychotic drugs detected in the heart but not the leg vein; because he died immediately after the injection, it is probable that the fluphenazine ester went inadvertently into a vein and was immediately hydrolysed. Patient 4 had high doses of pimozide, now known to be unsafe. He also had toxic levels of trifluoperazine; therefore, either or both drugs could be implicated. Death in patient 7 followed immediately after the injection, thereby implicating the drugs. He was possibly sensitive to antipsychotic medication.
The remaining five patients present varying combinations of drug treatment, but all had probab!y toxic levels of either an antipsychotic or an antidepressant drug, levels associated with sudden death. The first patient had toxic concentrations of both chlorpromazine and thioridazine although haloperidol was undetected. Patient 3 also had high concentrations of two antipsychotic drugs, chlorpromazine and trifluoperazine, but, again, halopendol levels were low. Patient 6 had high levels of chlorpromazine and other drugs and may have been sensitive to the antipsychotic drug. The last two patients (5 and 8) were treated with antipsychotic and antidepressant drugs, and various drug levels were in the toxic range. As predictable from pharmacokinetic principles, drugcombinations are particularly hazardous. One drug can inhibit the metabolism of another (e.g. Loga et a!, 1981) , the latter drug's reactions flipping from first-order to zero-order with rapid rises in bodily concentrations.
What is the mechanism of these sudden, unexplained deaths? The phenothiazines and tri-and tetracyclic antidepressants display electrophysio logical properties like those of the class IA antiarrhythmic agents (Fowler et a!, 1976; Cassem, 1982) . Of these, thioridazine and, less frequently, chlorpromazine, have been implicated in the develop ment of ventricular tachycardia, primarily in patients taking an overdose of these medications (Fowler et 
Recommendations
Our data suggest a few tentative recommendations (see also Brown & Kocsis, 1984) . It is essential that the role that neuroleptic drugs play in the cause of sudden unexpected death in psychiatric patients be clarified. The single most important procedure is to obtain an adequate sample of blood from a peripheral vein as soon as death is verified or the body discovered. In the UK, analysis of the sample can usually be arranged by the local Poisons Centre.
The choice of drug to sedate the disturbed patient should take into account the possibility that some drugs are potentially more toxic than others. Pimozide is the most obvious example, but chlorpromazine and thioridazine may present above average hazards. A survey in the Bethlem Royal and Maudsley Hospital (London) showed a combination of haloperidol and diazepam to be favoured for the acute incident (Pilowski et a!, 1992) . However, no clear favourite is evident for the longer-term treatment of the severely disturbed psychotic patient.
In these cases, certain precautions would seem wise before dosages are increased beyond British National Formu!ary recommendations. Firstly, every effort should be made to ensure that the patient undergoes a physical examination with particular attention to factors which might alter drug response; for example, liver failure. Next, baseline vital signs should be established so that any deviations as the dose of medication is increased can be detected promptly. If the patient becomes sleepy, monitoring of the respiration is particularly important. An electro cardiogram is a wise precaution. Any abnormalities such as prolonged Q-T interval or arrhythmia should be carefully assessed, preferably by a cardiologist. Because the electrolyte balance is important in governing cardiovascular function, this estimation should be repeated with particular attention to sodium, potassium, calcium, and magnesium. If the potassium level is low, supplements may be considered.
The actual drug regimen should be kept as simple as possible. When drug combinations are used, compounds with simple pharmacokinetic properties are preferable to those with many metabolic pathways. Thus, haloperidol is preferable to chlorpromazine; lorazepam to diazepam. Antidepressant drugs are particularly suspected of interfering with the metabolism of neuroleptics (Loga et a!, 1981) .
